Today’s oncology and hematology conferences connect healthcare providers (HCPs) such as yourself to the best researchers and thought leaders in the industry on local, regional, and global scales. Offering virtual, in-person, or hybrid experiences, these conferences are flexible and adaptable to your needs and exist to deliver the latest data and medical research in engaging and informative ways. Collected here are the current and upcoming events we think you may be interested in, including links to registration or more information.
Beyond the Congress™: Key Conversations From the 2020 Hematology Meeting is a 1-day national conference with the goal of disseminating recently presented data and emerging trends from the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition.
Presentations from key thought leaders will focus on how scientific advances will impact clinical practice in treating lymphoma, multiple myeloma, acute and chronic leukemias, and myeloproliferative neoplasms. Join us on February 5th for this complimentary educational experience!
Updates & Impacts™: Treating Hematologic Malignancies in 2021 is a 1-day conference with the goal of disseminating recently presented data and emerging trends from the ASH Annual Meeting and Exposition led by New York-Presbyterian faculty.
The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. Organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma who devoted his life to the understanding of this disease, IUCLS is a “live” virtual, multi-day program. Regional faculty participate in expert presentations, interactive case discussions, poster and abstract presentations, and Q&A sessions.
Sonali Smith, MD
University of Chicago
Barbara Pro, MD
Andy Evens, DO, MSc, FACP
Rutgers Cancer Institute of New Jersey
This live/virtual hybrid, multi-day conference features a comprehensive review into mechanisms of disease and treatments for patients with cancer or a blood disorder. Expert faculty from Winship Cancer Institute of Emory University and thought leaders from across the nation will engage in interactive debates, didactic lectures, and interactive Q&A sessions on controversial topics and standards of care, offering participants the opportunity to hear how science supports each point of view.
Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University
Suresh Ramalingam, MD, FASCO
Winship Cancer Institute of Emory University
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a 4-day live biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia and related lymphoproliferative disorders. Dedicated to advancing state-of-the-art and emerging concepts in the pathobiology and treatment of blood cancers, iwCLL is the largest international meeting of its kind, facilitating collaboration and the exchange of information among international leaders and scientists.
One of the conferences independently organized by Bio Ascend, this “live” virtual, 1-day program was created to empower women leaders in the hematology and oncology space. Providing essential clinical updates, career development, and professional networking, LEAD hosts national faculty during this annual event. Activities include a keynote presentation, professional vignettes, professional development workshops, and interactive panel discussions.
This Bio Ascend summit is an invitation-only meeting for international experts who treat hematologic malignancies and individuals from sponsoring industry. A “live” virtual, 1-day program, it offers keynote presentations, expert debates, interactive panel discussions, and breakout sessions. The 9th annual workshop will be held October 8, 2021.
Bio Ascend was creating dynamic virtual events even before today’s conference experience pivoted almost completely from in-person events to virtual engagements. By creating and developing interactive educational offerings, a virtual experience created by Bio Ascend still accomplishes the goal of disseminating recent data and emerging trends. By pairing “live” programs chaired by today’s leading experts with prerecorded clinical presentations, interactive case discussions and expert panel discussions, we continue to attract and engage with a global audience of oncology and hematology healthcare providers.